Quipt Home Medical Corp. (NASDAQ:QIPT – Free Report) – Stifel Canada increased their Q4 2025 EPS estimates for shares of Quipt Home Medical in a note issued to investors on Tuesday, February 11th. Stifel Canada analyst J. Keywood now expects that the company will earn $0.03 per share for the quarter, up from their prior estimate of $0.02. The consensus estimate for Quipt Home Medical’s current full-year earnings is ($0.05) per share.
Quipt Home Medical Stock Up 3.4 %
Shares of QIPT stock opened at $3.00 on Thursday. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.86 and a current ratio of 1.20. The firm’s 50-day moving average is $2.89 and its 200-day moving average is $2.86. The stock has a market cap of $129.27 million, a price-to-earnings ratio of -20.00 and a beta of 0.57. Quipt Home Medical has a 52-week low of $2.30 and a 52-week high of $4.98.
Insider Activity at Quipt Home Medical
In related news, VP Patrick Dennis Gamble purchased 17,000 shares of the firm’s stock in a transaction that occurred on Thursday, December 26th. The shares were acquired at an average price of $2.45 per share, for a total transaction of $41,650.00. Following the purchase, the vice president now owns 40,057 shares in the company, valued at approximately $98,139.65. This represents a 73.73 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 13.40% of the stock is owned by company insiders.
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently bought and sold shares of the stock. SG Americas Securities LLC acquired a new position in shares of Quipt Home Medical during the 3rd quarter worth approximately $44,000. Atom Investors LP acquired a new position in shares of Quipt Home Medical during the 3rd quarter worth approximately $51,000. XTX Topco Ltd acquired a new position in shares of Quipt Home Medical during the 3rd quarter worth approximately $54,000. Wells Fargo & Company MN grew its position in shares of Quipt Home Medical by 30.9% during the 4th quarter. Wells Fargo & Company MN now owns 23,851 shares of the company’s stock worth $73,000 after purchasing an additional 5,625 shares in the last quarter. Finally, JPMorgan Chase & Co. grew its position in shares of Quipt Home Medical by 68.7% during the 3rd quarter. JPMorgan Chase & Co. now owns 30,403 shares of the company’s stock worth $89,000 after purchasing an additional 12,383 shares in the last quarter. Institutional investors and hedge funds own 42.85% of the company’s stock.
Quipt Home Medical Company Profile
Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment.
Featured Articles
- Five stocks we like better than Quipt Home Medical
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Upstart’s Uptrend Is Just Getting Started: Its Time to Load Up
- ESG Stocks, What Investors Should Know
- Archer Aviation Lands BlackRock Investment—What’s Next for ACHR?
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Buffett Buys More Occidental Petroleum—Sticking to His Playbook
Receive News & Ratings for Quipt Home Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quipt Home Medical and related companies with MarketBeat.com's FREE daily email newsletter.